[Critical view on drug therapy for rheumatism].
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D011817:Rabbits; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000209:etiology; D012213:Rheumatic Fever / Q000188:drug therapy* / Q000209:etiology; D012459:Salicylates / Q000627:therapeutic use
D000700:Analgesics; D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D012459:Salicylates; D006046:Gold; D002738:Chloroquine
Kritisches zur medikamentösen Rheumabehandlung.